Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 28, 2018 - Issue 5
Submit an article Journal homepage
790
Views
7
CrossRef citations to date
0
Altmetric
Review

Farnesoid X receptor modulators 2014-present: a patent review

Valentina SepeDepartment of Pharmacy, University of Naples “Federico II”, Naples, ItalyView further author information
,
Eleonora DistruttiHospital S. Maria della Misericordia, Perugia, ItalyView further author information
,
Stefano FiorucciDepartment of Experimental and Clinical Medicine, University of Perugia, Perugia, ItalyView further author information
&
Angela ZampellaDepartment of Pharmacy, University of Naples “Federico II”, Naples, ItalyCorrespondence[email protected]
View further author information
Pages 351-364 | Received 15 Feb 2018, Accepted 19 Mar 2018, Published online: 13 Apr 2018

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Stefano Fiorucci, Michele Biagioli, Monia Baldoni, Patrizia Ricci, Valentina Sepe, Angela Zampella & Eleonora Distrutti. (2021) The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease. Expert Opinion on Drug Discovery 16:10, pages 1193-1208.
Read now
Rakesh Sahu, Rakhi Mishra & Chandana Majee. (2020) An insight into primary biliary cholangitis and its recent advances in treatment: semi-synthetic analogs to combat ursodeoxycholic-acid resistance. Expert Review of Gastroenterology & Hepatology 14:10, pages 985-998.
Read now
Kamran Qureshi & Brent A. Neuschwander-Tetri. (2020) The molecular basis for current targets of NASH therapies. Expert Opinion on Investigational Drugs 29:2, pages 151-161.
Read now
Marco Arrese, Francisco Barrera, Nicolas Triantafilo & Juan Pablo Arab. (2019) Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations. Expert Review of Gastroenterology & Hepatology 13:9, pages 849-866.
Read now
Christos Masaoutis & Stamatios Theocharis. (2019) The farnesoid X receptor: a potential target for expanding the therapeutic arsenal against kidney disease. Expert Opinion on Therapeutic Targets 23:2, pages 107-116.
Read now
Frank Tacke & Ralf Weiskirchen. (2018) An update on the recent advances in antifibrotic therapy. Expert Review of Gastroenterology & Hepatology 12:11, pages 1143-1152.
Read now
Hong Wang, Qingxian He, Guangji Wang, Xiaowei Xu & Haiping Hao. (2018) FXR modulators for enterohepatic and metabolic diseases. Expert Opinion on Therapeutic Patents 28:11, pages 765-782.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.